ATH-06

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameATH-06

Drug Alias NameAFFITOPE AT06A+adjuvantATH-06AT-06-A

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors

TargetsProprotein convertase subtilisin kexin type 9

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAffiris Ag

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAffiris Ag

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

ATC CodeN/A